Pharmacodynamic effects of clopidogrel in pediatric cardiac patients: A comparative study of platelet aggregation response

References

• Ts'ao CH. Comparable inhibition of aggregation of PRP of neonates and adults by aspirin. Haemostasis 1977; 6: 118–126
   PubMedGoogle Scholar
• Louden KA, Broughton Pipkin F, Heptinstall S, Fox SC, Tuohy P, O'Callaghan C, Mitchell JR, Symonds EM. Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: The effect of maternal low dose aspirin. Br J Obstet Gynaecol 1994; 101: 203–208
   PubMedGoogle Scholar
• Tanindi S, Kürekçi AE, Köseoğlu V, Kurt M, Ozcan O. The normalization period of platelet aggregation in newborns. Thromb Res 1995; 80: 57–62
   PubMed Web of Science ®Google Scholar
• Israels SJ, Odaibo FS, Robertson C, McMillan EM, McNicol A. Deficient thromboxane synthesis and response in platelets from premature infants. Pediatr Res 1997; 41: 218–223
   PubMed Web of Science ®Google Scholar
• Uçar T, Gurman C, Arsan S, Kemahli S. Platelet aggregation in term and preterm newborns. Pediatr Hematol Oncol 2005; 22: 139–145
   PubMed Web of Science ®Google Scholar
• Cvirn G, Kutschera J, Wagner T, Ferstl U, Vrecko K, Hallstrom S, Juergens G, Koestenberger M. Collagen/endogenous thrombin-induced platelet aggregation in cord versus adult whole blood. Neonatology 2009; 95: 187–192
   PubMed Web of Science ®Google Scholar
• Strauss T, Sidlik-Muskatel R, Kenet G. Developmental hemostasis: Primary hemostasis and evaluation of platelet function in neonates. Semin Fetal Neonatal Med 2011; 16(6)301–304
   PubMed Web of Science ®Google Scholar
• Saxonhouse MA, Garner R, Mammel L, Li Q, Muller KE, Greywoode J, Miller C, Sola-Visner M. Closure times measured by the platelet function analyzer PFA-100 are longer in neonatal blood compared to cord blood samples. Neonatology 2010; 97: 242–249
   PubMed Web of Science ®Google Scholar
• Gatti L, Guarneri D, Caccamo ML, Gianotti GA, Marini A. Platelet activation in newborns detected by flow-cytometry. Biol Neonate 1996; 70: 322–327
   PubMedGoogle Scholar
• Israels SJ, Daniels M, McMillan EM. Deficient collagen-induced activation in the newborn platelet. Pediatr Res 1990; 27: 337–343
   PubMed Web of Science ®Google Scholar
• Rajasekhar D, Barnard MR, Bednarek FJ, Michelson AD. Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 1997; 77: 1002–1007
   PubMed Web of Science ®Google Scholar
• Rajasekhar D, Kestin AS, Bednarek FJ, Ellis PA, Barnard MR, Michelson AD. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994; 72: 957–963
   PubMed Web of Science ®Google Scholar
• Heistein LC, Scott WA, Zellers TM, Fixler DE, Ramaciotti C, Journeycake JM, Lemler MS. Aspirin resistance in children with heart disease at risk for thromboembolism: Prevalence and possible mechanisms. Pediatr Cardiol 2008; 29: 285–291
   PubMed Web of Science ®Google Scholar
• Yee DL, Dinu BR, Sun CW, Edwards RM, Justino H, Teruya J, Bray PF, Bomgaars L. Low prevalence and assay discordance of “aspirin resistance” in children. Pediatr Blood Cancer 2008; 51: 86–92
   PubMed Web of Science ®Google Scholar
• Li JS, Yow E, Berezny KY, Bokesch PM, Takahashi M, Graham TP, Jr, Sanders SP, Sidi D, Bonnet D, Ewert P, et al. Dosing of clopidogrel for platelet inhibition in infants and young children: Primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trial. Circulation 2008; 117: 553–559
   PubMed Web of Science ®Google Scholar
• Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178–195
   PubMed Web of Science ®Google Scholar
• Folie BJ, McIntire LV. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow. Biophys J 1989; 56: 1121–1141
   PubMed Web of Science ®Google Scholar
• Knöfler R, Weissbach G, Kuhlisch E. Platelet function tests in childhood. Measuring aggregation and release reaction in whole blood. Semin Thromb Hemost 1998; 24: 513–521
   PubMed Web of Science ®Google Scholar
• Pietrucha T, Wojciechowski T, Greger J, Jd E, Nowak S, Chrul S, Golanski J, Watala C. Differentiated reactivity of whole blood neonatal platelets to various agonists. Platelets 2001; 12: 99–107
   PubMed Web of Science ®Google Scholar
• Schlagenhauf A, Schweintzger S, Birner-Gruenberger R, Leschnik B, Muntean W. Newborn platelets: Lower levels of protease-activated receptors cause hypoaggregability to thrombin. Platelets 2010; 21: 641–647
   PubMed Web of Science ®Google Scholar
• Hézard N, Potron G, Schlegel N, Amory C, Leroux B, Nguyen P. Unexpected persistence of platelet hyporeactivity beyond the neonatal period: A flow cytometric study in neonates, infants and older children. Thromb Haemost 2003; 90: 116–123
   PubMed Web of Science ®Google Scholar
• von Beckerath N, Kastrati A, Wieczorek A, Pogatsa-Murray G, Sibbing D, Graf I, Schomig A. A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. Eur Heart J 2007; 28: 1814–1819
   PubMed Web of Science ®Google Scholar
• Angiolillo DJ, Shoemaker SB, Desai B, Yuan H, Charlton RK, Bernardo E, Zenni MM, Guzman LA, Bass TA, Costa MA. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: Results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study. Circulation 2007; 115: 708–716
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908–2913
   PubMed Web of Science ®Google Scholar
• Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J. Variability in responsiveness to clopidogrel in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2006; 32: 71–75
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005; 45: 246–251
   PubMed Web of Science ®Google Scholar
• Michelson AD, Linden MD, Furman MI, Li Y, Barnard MR, Fox ML, Lau WC, McLaughlin TJ, Frelinger AL. Evidence that pre-existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’. J Thromb Haemost 2007; 5: 75–81
   PubMed Web of Science ®Google Scholar
• Serebruany V, Pokov I, Kuliczkowski W, Chesebro J, Badimon J. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease. Thromb Haemost 2008; 100: 76–82
   PubMed Web of Science ®Google Scholar
• Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin “resistance” and risk of cardiovascular morbidity: Systematic review and meta-analysis. BMJ 2008; 336: 195–198
   PubMed Web of Science ®Google Scholar
• Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis. Am Heart J 2007; 154: 221–231
   PubMed Web of Science ®Google Scholar
• Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009; 360: 354–362
   PubMed Web of Science ®Google Scholar
• Geisler T, Schaeffeler E, Dippon J, Winter S, Buse V, Bischofs C, Zuern C, Moerike K, Gawaz M, Schwab M. CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation. Pharmacogenomics 2008; 9: 1251–1259
   PubMed Web of Science ®Google Scholar